TY - JOUR AU - Rhijn, B. W. AU - Burger, M. AU - Lotan, Y. AU - Solsona, E. AU - Stief, C. G. AU - Sylvester, R. J. PY - 2009 DA - 2009// TI - Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy JO - Eur Urol VL - 56 UR - https://doi.org/10.1016/j.eururo.2009.06.028 DO - 10.1016/j.eururo.2009.06.028 ID - Rhijn2009 ER - TY - JOUR AU - Salminen, A. AU - Kaarniranta, K. AU - Kauppinen, A. PY - 2016 DA - 2016// TI - AMPK and HIF signaling pathways regulate both longevity and cancer growth: the good news and the bad news about survival mechanisms JO - Biogerontology. VL - 17 UR - https://doi.org/10.1007/s10522-016-9655-7 DO - 10.1007/s10522-016-9655-7 ID - Salminen2016 ER - TY - JOUR AU - Shi, W. Y. AU - Xiao, D. AU - Wang, L. AU - Dong, L. H. AU - Yan, Z. X. AU - Shen, Z. X. PY - 2012 DA - 2012// TI - Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy JO - Cell Death Dis VL - 3 UR - https://doi.org/10.1038/cddis.2012.13 DO - 10.1038/cddis.2012.13 ID - Shi2012 ER - TY - STD TI - Duan W, Chen K, Jiang Z, Chen X, Sun L, Li J, et al. Desmoplasia suppression by metformin-mediated AMPK activation inhibits pancreatic cancer progression. Cancer Lett. 2016. ID - ref4 ER - TY - JOUR AU - Faubert, B. AU - Boily, G. AU - Izreig, S. AU - Griss, T. AU - Samborska, B. AU - Dong, Z. PY - 2013 DA - 2013// TI - AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo JO - Cell Metab VL - 17 UR - https://doi.org/10.1016/j.cmet.2012.12.001 DO - 10.1016/j.cmet.2012.12.001 ID - Faubert2013 ER - TY - JOUR AU - Tseng, C. H. PY - 2014 DA - 2014// TI - Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes JO - Acta Diabetol VL - 51 UR - https://doi.org/10.1007/s00592-014-0562-6 DO - 10.1007/s00592-014-0562-6 ID - Tseng2014 ER - TY - JOUR AU - Giovannucci, E. AU - Harlan, D. M. AU - Archer, M. C. AU - Bergenstal, R. M. AU - Gapstur, S. M. AU - Habel, L. A. PY - 2010 DA - 2010// TI - Diabetes and cancer: a consensus report JO - Diabetes Care VL - 33 UR - https://doi.org/10.2337/dc10-0666 DO - 10.2337/dc10-0666 ID - Giovannucci2010 ER - TY - JOUR AU - Malek, M. AU - Aghili, R. AU - Emami, Z. AU - Khamseh, M. E. PY - 2013 DA - 2013// TI - Risk of cancer in diabetes: the effect of metformin JO - ISRN Endocrinol VL - 2013 UR - https://doi.org/10.1155/2013/636927 DO - 10.1155/2013/636927 ID - Malek2013 ER - TY - JOUR AU - Pierotti, M. A. AU - Berrino, F. AU - Gariboldi, M. AU - Melani, C. AU - Mogavero, A. AU - Negri, T. PY - 2013 DA - 2013// TI - Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects JO - Oncogene. VL - 32 UR - https://doi.org/10.1038/onc.2012.181 DO - 10.1038/onc.2012.181 ID - Pierotti2013 ER - TY - JOUR AU - Ahn, J. H. AU - Jung, S. I. AU - Yim, S. U. AU - Kim, S. W. AU - Hwang, E. C. AU - Kwon, D. D. PY - 2016 DA - 2016// TI - Impact of glycemic control and metformin use on the recurrence and progression of non-muscle invasive bladder Cancer in patients with diabetes mellitus JO - J Korean Med Sci VL - 31 UR - https://doi.org/10.3346/jkms.2016.31.9.1464 DO - 10.3346/jkms.2016.31.9.1464 ID - Ahn2016 ER - TY - JOUR AU - Courtois, S. AU - Duran, R. V. AU - Giraud, J. AU - Sifre, E. AU - Izotte, J. AU - Megraud, F. PY - 2017 DA - 2017// TI - Metformin targets gastric cancer stem cells JO - Eur J Cancer VL - 84 UR - https://doi.org/10.1016/j.ejca.2017.07.020 DO - 10.1016/j.ejca.2017.07.020 ID - Courtois2017 ER - TY - JOUR AU - Pan, Q. AU - Yang, G. L. AU - Yang, J. H. AU - Lin, S. L. AU - Liu, N. AU - Liu, S. S. PY - 2015 DA - 2015// TI - Metformin can block precancerous progression to invasive tumors of bladder through inhibiting STAT3-mediated signaling pathways JO - J Exp Clin Cancer Res VL - 34 UR - https://doi.org/10.1186/s13046-015-0183-0 DO - 10.1186/s13046-015-0183-0 ID - Pan2015 ER - TY - JOUR AU - Peng, M. AU - Huang, Y. AU - Tao, T. AU - Peng, C. Y. AU - Su, Q. AU - Xu, W. PY - 2016 DA - 2016// TI - Metformin and gefitinib cooperate to inhibit bladder cancer growth via both AMPK and EGFR pathways joining at Akt and Erk JO - Sci Rep VL - 6 UR - https://doi.org/10.1038/srep28611 DO - 10.1038/srep28611 ID - Peng2016 ER - TY - JOUR AU - Heidari, F. AU - Abbas Zade, S. AU - Mir Hosseini, S. H. AU - Ghadian, A. PY - 2016 DA - 2016// TI - Metformin for the prevention of bladder Cancer recurrence: is it effective? JO - Nephrourol Mon VL - 8 UR - https://doi.org/10.5812/numonthly.30261 DO - 10.5812/numonthly.30261 ID - Heidari2016 ER - TY - JOUR AU - Donnellan, R. AU - Chetty, R. PY - 1999 DA - 1999// TI - Cyclin E in human cancers JO - FASEB J VL - 13 UR - https://doi.org/10.1096/fasebj.13.8.773 DO - 10.1096/fasebj.13.8.773 ID - Donnellan1999 ER - TY - JOUR AU - Musat, M. AU - Morris, D. G. AU - Korbonits, M. AU - Grossman, A. B. PY - 2010 DA - 2010// TI - Cyclins and their related proteins in pituitary tumourigenesis JO - Mol Cell Endocrinol VL - 326 UR - https://doi.org/10.1016/j.mce.2010.03.017 DO - 10.1016/j.mce.2010.03.017 ID - Musat2010 ER - TY - JOUR AU - Kanska, J. AU - Zakhour, M. AU - Taylor-Harding, B. AU - Karlan, B. Y. AU - Wiedemeyer, W. R. PY - 2016 DA - 2016// TI - Cyclin E as a potential therapeutic target in high grade serous ovarian cancer JO - Gynecol Oncol VL - 143 UR - https://doi.org/10.1016/j.ygyno.2016.07.111 DO - 10.1016/j.ygyno.2016.07.111 ID - Kanska2016 ER - TY - JOUR AU - Freemantle, S. J. AU - Dmitrovsky, E. PY - 2010 DA - 2010// TI - Cyclin E transgenic mice: discovery tools for lung cancer biology, therapy, and prevention JO - Cancer Prev Res (Phila) VL - 3 UR - https://doi.org/10.1158/1940-6207.CAPR-10-0297 DO - 10.1158/1940-6207.CAPR-10-0297 ID - Freemantle2010 ER - TY - JOUR AU - Huang, L. N. AU - Wang, D. S. AU - Chen, Y. Q. AU - Li, W. AU - Hu, F. D. AU - Gong, B. L. PY - 2012 DA - 2012// TI - Meta-analysis for cyclin E in lung cancer survival JO - Clin Chim Acta VL - 413 UR - https://doi.org/10.1016/j.cca.2011.12.020 DO - 10.1016/j.cca.2011.12.020 ID - Huang2012 ER - TY - JOUR AU - Akli, S. AU - Zhang, X. Q. AU - Bondaruk, J. AU - Tucker, S. L. AU - Czerniak, P. B. AU - Benedict, W. F. PY - 2012 DA - 2012// TI - Low molecular weight cyclin E is associated with p27-resistant, high-grade, high-stage and invasive bladder cancer JO - Cell Cycle VL - 11 UR - https://doi.org/10.4161/cc.19882 DO - 10.4161/cc.19882 ID - Akli2012 ER - TY - JOUR AU - Kaczmarek, P. AU - Tosik, D. AU - Majewska, E. AU - Baj, Z. PY - 2006 DA - 2006// TI - Quantitative analysis of cyclin E and protein p34 cdc2 expression in superficial bladder cancer JO - Pol J Pathol VL - 57 ID - Kaczmarek2006 ER - TY - STD TI - Caruso JA, Duong MT, Carey JPW, Hunt KK, Keyomarsi K. Low-molecular-weight cyclin E in human Cancer: cellular consequences and opportunities for targeted therapies. Cancer Res. 2018. ID - ref22 ER - TY - JOUR AU - Camargo, F. D. AU - Gokhale, S. AU - Johnnidis, J. B. AU - Fu, D. AU - Bell, G. W. AU - Jaenisch, R. PY - 2007 DA - 2007// TI - YAP1 increases organ size and expands undifferentiated progenitor cells JO - Curr Biol VL - 17 UR - https://doi.org/10.1016/j.cub.2007.10.039 DO - 10.1016/j.cub.2007.10.039 ID - Camargo2007 ER - TY - JOUR AU - Dong, J. AU - Feldmann, G. AU - Huang, J. AU - Wu, S. AU - Zhang, N. AU - Comerford, S. A. PY - 2007 DA - 2007// TI - Elucidation of a universal size-control mechanism in Drosophila and mammals JO - Cell. VL - 130 UR - https://doi.org/10.1016/j.cell.2007.07.019 DO - 10.1016/j.cell.2007.07.019 ID - Dong2007 ER - TY - JOUR AU - Mo, J. S. AU - Park, H. W. AU - Guan, K. L. PY - 2014 DA - 2014// TI - The hippo signaling pathway in stem cell biology and cancer JO - EMBO Rep VL - 15 UR - https://doi.org/10.15252/embr.201438638 DO - 10.15252/embr.201438638 ID - Mo2014 ER - TY - JOUR AU - Kang, W. AU - Tong, J. H. AU - Chan, A. W. AU - Lee, T. L. AU - Lung, R. W. AU - Leung, P. P. PY - 2011 DA - 2011// TI - Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-10-2467 DO - 10.1158/1078-0432.CCR-10-2467 ID - Kang2011 ER - TY - JOUR AU - Sohn, B. H. AU - Shim, J. J. AU - Kim, S. B. AU - Jang, K. Y. AU - Kim, S. M. AU - Kim, J. H. PY - 2016 DA - 2016// TI - Inactivation of hippo pathway is significantly associated with poor prognosis in hepatocellular carcinoma JO - Clin Cancer Res VL - 22 UR - https://doi.org/10.1158/1078-0432.CCR-15-1447 DO - 10.1158/1078-0432.CCR-15-1447 ID - Sohn2016 ER - TY - JOUR AU - Diep, C. H. AU - Zucker, K. M. AU - Hostetter, G. AU - Watanabe, A. AU - Hu, C. AU - Munoz, R. M. PY - 2012 DA - 2012// TI - Down-regulation of yes associated protein 1 expression reduces cell proliferation and clonogenicity of pancreatic cancer cells JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0032783 DO - 10.1371/journal.pone.0032783 ID - Diep2012 ER - TY - JOUR AU - Wang, Y. AU - Dong, Q. AU - Zhang, Q. AU - Li, Z. AU - Wang, E. AU - Qiu, X. PY - 2010 DA - 2010// TI - Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer JO - Cancer Sci VL - 101 UR - https://doi.org/10.1111/j.1349-7006.2010.01511.x DO - 10.1111/j.1349-7006.2010.01511.x ID - Wang2010 ER - TY - JOUR AU - Pei, T. AU - Li, Y. AU - Wang, J. AU - Wang, H. AU - Liang, Y. AU - Shi, H. PY - 2015 DA - 2015// TI - YAP is a critical oncogene in human cholangiocarcinoma JO - Oncotarget. VL - 6 UR - https://doi.org/10.18632/oncotarget.4043 DO - 10.18632/oncotarget.4043 ID - Pei2015 ER - TY - JOUR AU - Liu, J. Y. AU - Li, Y. H. AU - Lin, H. X. AU - Liao, Y. J. AU - Mai, S. J. AU - Liu, Z. W. PY - 2013 DA - 2013// TI - Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder JO - BMC Cancer VL - 13 UR - https://doi.org/10.1186/1471-2407-13-349 DO - 10.1186/1471-2407-13-349 ID - Liu2013 ER - TY - JOUR AU - Shen, Y. J. AU - Kong, Z. L. AU - Wan, F. N. AU - Wang, H. K. AU - Bian, X. J. AU - Gan, H. L. PY - 2014 DA - 2014// TI - Downregulation of DAB2IP results in cell proliferation and invasion and contributes to unfavorable outcomes in bladder cancer JO - Cancer Sci VL - 105 UR - https://doi.org/10.1111/cas.12407 DO - 10.1111/cas.12407 ID - Shen2014 ER - TY - JOUR AU - Tian, Y. AU - Tang, B. AU - Wang, C. AU - Sun, D. AU - Zhang, R. AU - Luo, N. PY - 2016 DA - 2016// TI - Metformin mediates resensitivity to 5-fluorouracil in hepatocellular carcinoma via the suppression of YAP JO - Oncotarget. VL - 7 UR - https://doi.org/10.18632/oncotarget.10079 DO - 10.18632/oncotarget.10079 ID - Tian2016 ER - TY - JOUR AU - Yuan, X. AU - Wei, W. AU - Bao, Q. AU - Chen, H. AU - Jin, P. AU - Jiang, W. PY - 2018 DA - 2018// TI - Metformin inhibits glioma cells stemness and epithelial-mesenchymal transition via regulating YAP activity JO - Biomed Pharmacother VL - 102 UR - https://doi.org/10.1016/j.biopha.2018.03.031 DO - 10.1016/j.biopha.2018.03.031 ID - Yuan2018 ER - TY - JOUR AU - Mo, J. S. AU - Meng, Z. AU - Kim, Y. C. AU - Park, H. W. AU - Hansen, C. G. AU - Kim, S. PY - 2015 DA - 2015// TI - Cellular energy stress induces AMPK-mediated regulation of YAP and the hippo pathway JO - Nat Cell Biol VL - 17 UR - https://doi.org/10.1038/ncb3111 DO - 10.1038/ncb3111 ID - Mo2015 ER - TY - JOUR AU - Zhang, T. AU - Guo, P. AU - Zhang, Y. AU - Xiong, H. AU - Yu, X. AU - Xu, S. PY - 2013 DA - 2013// TI - The antidiabetic drug metformin inhibits the proliferation of bladder cancer cells in vitro and in vivo JO - Int J Mol Sci VL - 14 UR - https://doi.org/10.3390/ijms141224603 DO - 10.3390/ijms141224603 ID - Zhang2013 ER - TY - JOUR AU - Liu, Q. AU - Yuan, W. AU - Tong, D. AU - Liu, G. AU - Lan, W. AU - Zhang, D. PY - 2016 DA - 2016// TI - Metformin represses bladder cancer progression by inhibiting stem cell repopulation via COX2/PGE2/STAT3 axis JO - Oncotarget. VL - 7 ID - Liu2016 ER - TY - JOUR AU - WANG, D. O. N. G. AU - WU, X. I. A. O. H. O. U. PY - 2015 DA - 2015// TI - In vitro and in vivo targeting of bladder carcinoma with metformin in combination with cisplatin JO - Oncology Letters VL - 10 UR - https://doi.org/10.3892/ol.2015.3267 DO - 10.3892/ol.2015.3267 ID - WANG2015 ER - TY - JOUR AU - Hardie, D. G. AU - Ross, F. A. AU - Hawley, S. A. PY - 2012 DA - 2012// TI - AMPK: a nutrient and energy sensor that maintains energy homeostasis JO - Nat Rev Mol Cell Biol VL - 13 UR - https://doi.org/10.1038/nrm3311 DO - 10.1038/nrm3311 ID - Hardie2012 ER - TY - BOOK PY - 2016 DA - 2016// TI - AMP-activated Protein Kinase PB - Springer International Publishing CY - Cham ID - ref40 ER - TY - JOUR AU - Li, W. AU - Saud, S. M. AU - Young, M. R. AU - Chen, G. AU - Hua, B. PY - 2015 DA - 2015// TI - Targeting AMPK for cancer prevention and treatment JO - Oncotarget. VL - 6 ID - Li2015 ER - TY - JOUR AU - Rios, M. AU - Foretz, M. AU - Viollet, B. AU - Prieto, A. AU - Fraga, M. AU - Costoya, J. A. PY - 2013 DA - 2013// TI - AMPK activation by oncogenesis is required to maintain cancer cell proliferation in astrocytic tumors JO - Cancer Res VL - 73 UR - https://doi.org/10.1158/0008-5472.CAN-12-0861 DO - 10.1158/0008-5472.CAN-12-0861 ID - Rios2013 ER - TY - JOUR AU - Kopsiaftis, S. AU - Sullivan, K. L. AU - Garg, I. AU - Taylor, J. A. AU - Claffey, K. P. PY - 2016 DA - 2016// TI - AMPKalpha2 regulates bladder Cancer growth through SKP2-mediated degradation of p27 JO - Mol Cancer Res VL - 14 UR - https://doi.org/10.1158/1541-7786.MCR-16-0111 DO - 10.1158/1541-7786.MCR-16-0111 ID - Kopsiaftis2016 ER - TY - JOUR AU - Zhang, T. AU - Wang, X. AU - He, D. AU - Jin, X. AU - Guo, P. PY - 2014 DA - 2014// TI - Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP JO - Anti-Cancer Drugs VL - 25 UR - https://doi.org/10.1097/CAD.0000000000000116 DO - 10.1097/CAD.0000000000000116 ID - Zhang2014 ER - TY - JOUR AU - Li, F. AU - Zeng, J. AU - Gao, Y. AU - Guan, Z. AU - Ma, Z. AU - Shi, Q. PY - 2015 DA - 2015// TI - G9a Inhibition Induces Autophagic Cell Death via AMPK/mTOR Pathway in Bladder Transitional Cell Carcinoma JO - PloS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0138390 DO - 10.1371/journal.pone.0138390 ID - Li2015 ER - TY - JOUR AU - Dong, L. AU - Lin, F. AU - Wu, W. AU - Huang, W. AU - Cai, Z. PY - 2016 DA - 2016// TI - Transcriptional cofactor Mask2 is required for YAP-induced cell growth and migration in bladder cancer cell JO - J Cancer VL - 7 UR - https://doi.org/10.7150/jca.16438 DO - 10.7150/jca.16438 ID - Dong2016 ER - TY - JOUR AU - Ciamporcero, E. AU - Shen, H. AU - Ramakrishnan, S. AU - Yu Ku, S. AU - Chintala, S. AU - Shen, L. PY - 2016 DA - 2016// TI - YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage JO - Oncogene. VL - 35 UR - https://doi.org/10.1038/onc.2015.219 DO - 10.1038/onc.2015.219 ID - Ciamporcero2016 ER - TY - JOUR AU - Ciamporcero, E. AU - Daga, M. AU - Pizzimenti, S. AU - Roetto, A. AU - Dianzani, C. AU - Compagnone, A. PY - 2018 DA - 2018// TI - Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer JO - Free Radic Biol Med VL - 115 UR - https://doi.org/10.1016/j.freeradbiomed.2017.12.005 DO - 10.1016/j.freeradbiomed.2017.12.005 ID - Ciamporcero2018 ER - TY - JOUR AU - Zhao, A. Y. AU - Dai, Y. J. AU - Lian, J. F. AU - Huang, Y. AU - Lin, J. G. AU - Dai, Y. B. PY - 2018 DA - 2018// TI - YAP regulates ALDH1A1 expression and stem cell property of bladder cancer cells JO - Onco Targets Ther VL - 11 UR - https://doi.org/10.2147/OTT.S170858 DO - 10.2147/OTT.S170858 ID - Zhao2018 ER - TY - JOUR AU - DeRan, M. AU - Yang, J. AU - Shen, C. H. AU - Peters, E. C. AU - Fitamant, J. AU - Chan, P. PY - 2014 DA - 2014// TI - Energy stress regulates hippo-YAP signaling involving AMPK-mediated regulation of angiomotin-like 1 protein JO - Cell Rep VL - 9 UR - https://doi.org/10.1016/j.celrep.2014.09.036 DO - 10.1016/j.celrep.2014.09.036 ID - DeRan2014 ER - TY - JOUR AU - Chen, M. AU - Wu, R. AU - Li, G. AU - Liu, C. AU - Tan, L. AU - Xiao, K. PY - 2018 DA - 2018// TI - Motor neuron and pancreas homeobox 1/HLXB9 promotes sustained proliferation in bladder cancer by upregulating CCNE1/2 JO - J Exp Clin Cancer Res VL - 37 UR - https://doi.org/10.1186/s13046-018-0829-9 DO - 10.1186/s13046-018-0829-9 ID - Chen2018 ER - TY - JOUR AU - Fu, Y. P. AU - Kohaar, I. AU - Moore, L. E. AU - Lenz, P. AU - Figueroa, J. D. AU - Tang, W. PY - 2014 DA - 2014// TI - The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease JO - Cancer Res VL - 74 UR - https://doi.org/10.1158/0008-5472.CAN-14-1531 DO - 10.1158/0008-5472.CAN-14-1531 ID - Fu2014 ER - TY - JOUR AU - Song, B. N. AU - Kim, S. K. AU - Chu, I. S. PY - 2017 DA - 2017// TI - Bioinformatic identification of prognostic signature defined by copy number alteration and expression of CCNE1 in non-muscle invasive bladder cancer JO - Exp Mol Med VL - 49 UR - https://doi.org/10.1038/emm.2016.120 DO - 10.1038/emm.2016.120 ID - Song2017 ER - TY - JOUR AU - Conconi, D. AU - Sala, E. AU - Bovo, G. AU - Strada, G. AU - Dalpra, L. AU - Lavitrano, M. PY - 2016 DA - 2016// TI - Using copy number alterations to identify new therapeutic targets for bladder carcinoma JO - Int J Mol Sci VL - 17 UR - https://doi.org/10.3390/ijms17030271 DO - 10.3390/ijms17030271 ID - Conconi2016 ER - TY - JOUR AU - Li, Z. AU - Zhao, B. AU - Wang, P. AU - Chen, F. AU - Dong, Z. AU - Yang, H. PY - 2010 DA - 2010// TI - Structural insights into the YAP and TEAD complex JO - Genes Dev VL - 24 UR - https://doi.org/10.1101/gad.1865810 DO - 10.1101/gad.1865810 ID - Li2010 ER - TY - JOUR AU - Takeuchi, S. AU - Kasamatsu, A. AU - Yamatoji, M. AU - Nakashima, D. AU - Endo-Sakamoto, Y. AU - Koide, N. PY - 2017 DA - 2017// TI - TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phase JO - Biochem Biophys Res Commun VL - 486 UR - https://doi.org/10.1016/j.bbrc.2017.03.050 DO - 10.1016/j.bbrc.2017.03.050 ID - Takeuchi2017 ER - TY - JOUR AU - Wei, H. AU - Wang, F. AU - Wang, Y. AU - Li, T. AU - Xiu, P. AU - Zhong, J. PY - 2017 DA - 2017// TI - Verteporfin suppresses cell survival, angiogenesis and vasculogenic mimicry of pancreatic ductal adenocarcinoma via disrupting the YAP-TEAD complex JO - Cancer Sci VL - 108 UR - https://doi.org/10.1111/cas.13138 DO - 10.1111/cas.13138 ID - Wei2017 ER -